相关实验视频

Updated: May 2, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

多变量回归模型提高了Mycobacterium tuberculosis中抗生素耐药性突变的准确性和敏感分级

Sanjana G Kulkarni¹, Sacha Laurent², Paolo Miotto³

¹Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

Nature communications

|March 3, 2025

概括

一种新的回归方法通过识别比当前的世卫组织标准更多的耐药性相关突变,提高了对结核菌菌复合体 (MTBC) 的药物耐药性检测. 这改善了基于基因型的结核病治疗敏感性测试.

科学领域:

遗传学遗传学是一种遗传学.
微生物学微生物学
计算生物学计算生物学

背景情况:

针对Mycobacterium tuberculosis complex (MTBC) 的基于基因型的快速药物敏感性测试对于有效的结核病治疗至关重要.
对抗性相关突变的现有知识库对于这些测试至关重要.
世界卫生组织 (WHO) 提供了一个突变目录作为指导.

研究的目的:

开发和基准测试一种新的基于回归的方法,用于识别MTBC中与耐药性相关的突变.
将这个新目录的表现与世卫组织第二版目录进行比较.
评估基于回归的目录对改进基于基因型的药物敏感性测试的有用性.

主要方法:

多变量逻辑回归模型在超过52,000个MTBC分离物上进行了训练.
15种抗结核药物的二进制耐药表型与候选耐药基因的变异有关.
基于回归的目录与世卫组织的SOLO方法进行了比较.

主要成果:

回归方法检测到SOLO方法识别的变异的98%,并且总体上发现了29%的变异.
与SOLO相比,回归目录显示了较高的平均灵敏度 (+3.2pp),略低的特异性 (-1.0pp) 和正预测值 (-1.6pp).
对于乙醇,克洛法齐明,链杆菌素和埃西奥纳米德,观察到显著的敏感性增加.
回归方法还确定了对异化物耐药性的补偿突变以及与贝达基林和氨基糖化物过敏性相关的变异.

结论:

基于回归的目录代表了在识别MTBC耐药性相关突变方面取得的重大进展.
这种方法为几个关键的抗结核药物提供了更好的灵敏度,为下一代测序和分子分析的发展提供了信息.
虽然符合大多数世卫组织目标产品配置文件,但利法素的特异性需要进一步优化 (目前为97%)

更多相关视频

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...